Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study
Completed
Conditions studied: Venous Thromboembolism, Anticoagulants and Bleeding Disorders
In brief
The proposed research seeks to provide insights on the contemporary epidemiology, treatment, and outcomes of VTE, including examining the uptake of new treatment strategies, the efficacy and safety of different anticoagulant options, and the impact of venous thromboembolism on patient-defined outcomes, such as quality-of-life, symptom burden, and treatment satisfaction. This information is crucial to helping clinicians and patients choose between various treatment options for venous thromboembolism in order to achieve the best possible balance between the risks, benefits, and impact on health.
Key facts
- Study ID
- NCT03292666
- Run by
- University of California, San Francisco
- People needed
- 39603
- Starts
- 2010-01-01
- Expected to finish
- 2022-06-21
- Last updated by the study team
- 2022-11-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults (age ≥ 18 years) enrolled in Kaiser Permanente Northern California or Kaiser Permanente Southern California
- Index VTE event, defined as an incident clinical encounter (inpatient, emergency department, or outpatient) with a primary or secondary diagnosis of VTE during the time period January 1, 2010 to December 31, 2018
- Anticoagulant prescription (oral or parenteral) filled after index VTE discharge/encounter date
- Continuous outpatient anticoagulant therapy for ≥ 3 months from fill date of prescription
- Continuous pharmacy benefits and health plan membership for at least 12 months before the index VTE event date
You may not qualify if…
- Incomplete information on age and sex
Where it is running
- Kaiser Permanente Northern California — Oakland, California, United States
- Kaiser Permanente Southern California — Pasadena, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.